Norbert Arnold

Affiliations: 
Ludwig-Maximilians-Universität München, München, Bayern, Germany 
Google:
"Norbert Arnold"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dumont M, Weber-Lassalle N, Joly-Beauparlant C, et al. (2022) Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry. Cancers. 14
Rolfes M, Borde J, Möllenhoff K, et al. (2022) Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancers. 14
Lakeman IMM, van den Broek AJ, Vos JAM, et al. (2021) The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant. Genetics in Medicine : Official Journal of the American College of Medical Genetics
Coignard J, Lush M, Beesley J, et al. (2021) Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nature Communications. 12: 2986
Coignard J, Lush M, Beesley J, et al. (2021) A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nature Communications. 12: 1078
Dorling L, Carvalho S, et al. (2021) Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. The New England Journal of Medicine
Borde J, Ernst C, Wappenschmidt B, et al. (2020) Performance of breast cancer polygenic risk scores in 760 female CHEK2 germline mutation carriers. Journal of the National Cancer Institute
Barnes DR, Rookus MA, McGuffog L, et al. (2020) Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants. Genetics in Medicine : Official Journal of the American College of Medical Genetics
Liu J, Prager-van der Smissen WJC, Collée JM, et al. (2020) Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Scientific Reports. 10: 9688
Wappenschmidt B, Hauke J, Faust U, et al. (2020) Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer. Geburtshilfe Und Frauenheilkunde. 80: 410-429
See more...